Cargando…

Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model

The SARS-CoV-2 main viral protease (M(pro)) is an attractive target for antivirals given its distinctiveness from host proteases, essentiality in the viral life cycle and conservation across coronaviridae. We launched the COVID Moonshot initiative to rapidly develop patent-free antivirals with open...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morris, Aaron, McCorkindale, William, Consortium, The COVID Moonshot, Drayman, Nir, Chodera, John D., Tay, Savaş, London, Nir, Lee, Alpha A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204246/ https://www.ncbi.nlm.nih.gov/pubmed/34008627 http://dx.doi.org/10.1039/d1cc00050k

Ejemplares similares

Turning high-throughput structural biology into predictive inhibitor design
por: Saar, Kadi L., et al.
Publicado: (2023)

HSV-1 single-cell analysis reveals the activation of anti-viral and developmental programs in distinct sub-populations
por: Drayman, Nir, et al.
Publicado: (2019)

Computer vision reveals hidden variables underlying NF-κB activation in single cells
por: Patel, Parthiv, et al.
Publicado: (2021)

Quantitative interpretation explains machine learning models for chemical reaction prediction and uncovers bias
por: Kovács, Dávid Péter, et al.
Publicado: (2021)

Fixed single-cell RNA sequencing for understanding virus infection and host response
por: Van Phan, Hoang, et al.
Publicado: (2021)

High-throughput RNA sequencing of paraformaldehyde-fixed single cells
por: Phan, Hoang Van, et al.
Publicado: (2021)

Observed High Coinfection Rates Seem To Be a Result of Overlapping Plaques
por: Drayman, Nir
Publicado: (2017)

mSphere of Influence: Virology in the noise—how cell-to-cell variability impacts viral infection outcomes
por: Drayman, Nir
Publicado: (2023)

Expanding the Repertoire of Low‐Molecular‐Weight Pentafluorosulfanyl‐Substituted Scaffolds
por: Jose, Arathy, et al.
Publicado: (2022)

Data-driven discovery of molecular photoswitches with multioutput Gaussian processes
por: Griffiths, Ryan-Rhys, et al.
Publicado: (2022)

Ultra-sensitive digital quantification of proteins and mRNA in single cells
por: Lin, Jing, et al.
Publicado: (2019)

In crystallo-screening for discovery of human norovirus 3C-like protease inhibitors
por: Guo, Jingxu, et al.
Publicado: (2020)

Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
por: Huff, Sarah, et al.
Publicado: (2021)

Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells
por: Vanhoutte, Roeland, et al.
Publicado: (2023)

Virus strategies for passing the nuclear envelope barrier
por: Kobiler, Oren, et al.
Publicado: (2012)

Rapid recruitment of large cohort to support trials in general practice: the role of FARSITE
por: Bower, Peter, et al.
Publicado: (2015)

Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Douangamath, Alice, et al.
Publicado: (2020)

The Key Factors Predicting Dementia in Individuals With Alzheimer’s Disease-Type Pathology
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease
por: Deodato, Davide, et al.
Publicado: (2022)

Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
por: Dong, Jie, et al.
Publicado: (2022)

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease
por: Andrianov, Alexander M., et al.
Publicado: (2023)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor
por: Wen, Lei, et al.
Publicado: (2021)

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
por: Elkaeed, Eslam B., et al.
Publicado: (2022)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

Understanding the implementation of ‘sick day guidance’ to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation
por: Martindale, Anne-Marie, et al.
Publicado: (2017)

Transcriptional dynamics of microRNAs and their targets during Drosophila neurogenesis
por: Menzel, Peter, et al.
Publicado: (2019)

Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support people previously treated for melanoma: concise report of a qualitative study
por: Ntessalen, Maria, et al.
Publicado: (2023)

Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
por: Cheng, Bijun, et al.
Publicado: (2020)

Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2022)

Discovery of 4′-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor
por: Wu, Qianqian, et al.
Publicado: (2022)

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
por: Muhtar, Eldar, et al.
Publicado: (2021)

Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases
por: Kühl, Nikos, et al.
Publicado: (2022)

Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method
por: Zhang, Huijun, et al.
Publicado: (2023)

De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
por: Ben-Uliel, Shulamit Fluss, et al.
Publicado: (2022)

The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease
por: Bakerly, Nawar Diar, et al.
Publicado: (2021)

Implications of the LHCb discovery of CP violation in charm decays
por: Dery, Avital, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t6m50qhfvb2v60nrk6ob6ubo6h